Comparing patient characteristics and outcomes in type 1 versus type 2 diabetes with diabetic ketoacidosis: a review and a propensity-matched nationwide analysis.


Journal

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
ISSN: 1708-8267
Titre abrégé: J Investig Med
Pays: England
ID NLM: 9501229

Informations de publication

Date de publication:
08 2021
Historique:
accepted: 14 04 2021
pubmed: 12 5 2021
medline: 3 2 2022
entrez: 11 5 2021
Statut: ppublish

Résumé

Diabetic ketoacidosis (DKA) is a known complication of patients with type 1 diabetes mellitus (T1DM), but less common in type 2 diabetes mellitus (T2DM). The aim of this study was to compare the outcomes of patients admitted to the hospital with DKA in T1DM versus T2DM. This was a population-based, retrospective, cohort study using data from the Nationwide Inpatient Sample. The group of patients hospitalized for DKA was divided based on a secondary diagnosis of either T1DM or T2DM. The primary outcome was inpatient mortality, and the secondary outcomes were rate of complications, length of hospital stay (LOS) and total hospital charge (THC). The inpatient mortality for DKA was 0.27% (650 patients). In T2DM, the adjusted OR (aOR) for mortality was 2.13 (95% CI 1.38 to 3.28, p=0.001) with adjusted increase in mean THC of $6035 (95% CI 4420 to 7652, p<0.001) and mean LOS of 0.5 day (95% CI 0.3 to 0.6, p<0.001) compared with T1DM. Patients with T2DM had significantly higher odds of having septic shock (aOR 2.02, 95% CI 1.160 to 3.524, p=0.013) compared with T1DM. T2DM was associated with higher inpatient mortality, septic shock and increase in healthcare utilization costs compared with T1DM.

Identifiants

pubmed: 33972382
pii: jim-2021-001901
doi: 10.1136/jim-2021-001901
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1200

Informations de copyright

© American Federation for Medical Research 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Hafeez Shaka (H)

Department of Internal Medicine, John H Stroger Hospital of Cook County, Chicago, Illinois, USA sagehafeez@gmail.com.

Farah Wani (F)

Department of Internal Medicine, Samaritan Medical Center, Watertown, New York, USA.

Zain El-Amir (Z)

Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA.

Dushyant Singh Dahiya (DS)

Department of Internal Medicine, Central Michigan University, Saginaw, Michigan, USA.

Jagmeet Singh (J)

Department of Internal Medicine, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.

Ehizogie Edigin (E)

Department of Internal Medicine, John H Stroger Hospital of Cook County, Chicago, Illinois, USA.

Precious Eseaton (P)

Department of Medicine and Surgery, University of Benin, Benin City, Edo, Nigeria.

Asim Kichloo (A)

CMU Medical Education Partners, Saginaw, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH